OBLN News and Press, Obalon Therapeutics From 12/07/20

Gainers: Obalon Therapeutics (OBLN) +116%, Oncternal Therapeutics (ONCT) +77%, Fate Therapeutics (FATE) +41%, Constellation Pharmaceuticals (CNST) +33%, Nkarta (NKTX) +28%.Losers: scPharmaceuticals (SCPH) -33%, Aptose Biosciences (APTO) -...

Eastman Kodak (KODK) +76%. as DFC says no laws were broken.Greenland Technologies Holding (GTEC) +60% on launching 'electric industrial vehicle market' divisionObalon Therapeutics (OBLN) +52%.Oncternal Therapeutics (ONCT) +27% on presentation of interim phase 1/2 data...

3 Penny Stocks To Buy Under $3 Right Now; Are They On Your List? Trading penny stocks can be stressful, this is true. But what’s the main stressor that you usually encounter? This can be different for different traders. Some have a tough time knowing when to take a profit. Ot...

Gainers: [[OBLN]] +81%. [[MRIN]] +9.8%. [[FATE]] +8.8%. [[CRNX]] +6.7%. [[PROG]] +6.1%.Losers: [[HX]] -6.2%. [[INN]] -6.2%. [[RIDE]] -5.6%. [[MBIO]] -4.4%. [[EVK]] -3.8%. For further details see: RIDE, FATE, MBIO and MRIN among after-hours movers

Express (EXPR) -27% on Q3 earnings release.Splunk (SPLK) -21% on Q3 earnings release.Veritone (VERI) -20% on planned stock offering.Golar LNG (GLNG) -11% after launch offer of 11M shares in public offering.Merrimack Pharmaceuticals (MACK) -10%.AMC ...

Will These Penny Stocks Continue Showing Bullish Interest This Month? With November behind us, December is a new month to find penny stocks to watch. Although we are only a few days into the month, some penny stocks are already finding their stride. While searching for penny stocks ...

Obalon Therapeutics (OBLN): Q3 GAAP EPS of -$0.20 misses by $0.13.Revenue of $0.04M (-87.9% Y/Y)Press Release For further details see: Obalon Therapeutics EPS misses by $0.13

SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial ...

Morgan Stanley reports 5.9% passive stake in Obalon Therapeutics (NASDAQ: OBLN )   +8%  representing 456K shares. More news on: Obalon Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that it has executed a consultin...